The same authors also showed that patients bearing the CCND1 A/A and A/G genotypes (of cyclin D1) displayed a 1.811-fold increased risk of cervical cancer (95% CI = 1.150–2.852, P = 0.0098). This evidence concerns the gene CCND1 and cervical carcinoma.